Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence.
He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.
BMI has long been considered a standard measure of body fatness. However, it is time to reevaluate the use of...
Mobile clinics, once a cornerstone of healthcare delivery, are experiencing a resurgence and a renewed focus on access to care.
As the nation grapples with the overdose epidemic, the legal battle surrounding Purdue Pharma's bankruptcy immunity has taken center stage.
While the rhetoric surrounding closing the border may seem appealing, it is essential to critically analyze the potential consequences.
By understanding the mechanics behind virality, we can better comprehend the influence of social media on medical conversations.
Loneliness has become a widespread issue in today's society, with negative impacts on both our mental and physical health.
Prolonged exposure to Christmas trees can lead to respiratory and skin health issues, particularly for individuals with asthma or allergies.
Compulsive buying during the holiday season can have significant impacts on individuals' mental health and financial well-being.
The development and application of CRISPR-Cas9 bring hope for a cure, addressing the condition at a genetic level.
The new classification recognizes atrial fibrillation as a disease continuum and emphasizes a holistic approach to management.
White lung pneumonia, also known as pediatric white lung syndrome, is not exactly a novel pneumonia of unknown origin.
Nikki Haley is having a political moment. How will her beliefs shape Conservative perspectives on abortion?
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy